NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 193 filers reported holding NPS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $8,257,000 | -23.5% | 232,100 | -44.1% | 0.01% | -26.3% |
Q3 2014 | $10,794,000 | -5.1% | 415,139 | +5.8% | 0.02% | -5.0% |
Q2 2014 | $11,373,000 | +114.7% | 392,196 | +106.9% | 0.02% | +122.2% |
Q1 2014 | $5,296,000 | -65.9% | 189,521 | -55.6% | 0.01% | -69.0% |
Q4 2013 | $15,537,000 | +67.9% | 426,462 | +46.6% | 0.03% | +81.2% |
Q3 2013 | $9,251,000 | +263.1% | 290,827 | +72.4% | 0.02% | +220.0% |
Q2 2013 | $2,548,000 | – | 168,700 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARVEY CAPITAL MANAGEMENT INC | 431,475 | $15,433,000 | 5.92% |
SECTORAL ASSET MANAGEMENT INC | 1,623,073 | $58,057,000 | 2.60% |
Palo Alto Investors LP | 1,190,263 | $42,576,000 | 2.50% |
Fiera Capital (Europe) Ltd. | 426,250 | $3,246,000 | 2.39% |
BENDER ROBERT & ASSOCIATES | 75,080 | $2,686,000 | 1.76% |
FCG ADVISORS, LLC | 76,865 | $3,138,000 | 1.55% |
Penn Capital Management Company, LLC | 857,621 | $30,677,000 | 1.29% |
NEXT CENTURY GROWTH INVESTORS LLC | 927,285 | $33,168,000 | 1.20% |
Tekla Capital Management LLC | 625,900 | $22,388,000 | 1.05% |
Orbimed Advisors | 2,954,900 | $105,697,000 | 1.01% |